![]() |
Integer Holdings Corporation (ITGR) DCF -Bewertung
US | Healthcare | Medical - Devices | NYSE
|

- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Integer Holdings Corporation (ITGR) Bundle
Unabhängig davon, ob Sie ein Investor oder Analyst sind, ist dieser (ITGR) DCF-Taschenrechner Ihre Anlaufstelle für eine genaue Bewertung. Ausgestattet mit echten Daten der Integer Holdings Corporation können Sie Prognosen anpassen und die Auswirkungen in Echtzeit beobachten.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 1,073.4 | 1,221.1 | 1,376.1 | 1,596.7 | 1,716.6 | 1,931.1 | 2,172.5 | 2,444.0 | 2,749.4 | 3,093.0 |
Revenue Growth, % | 0 | 13.75 | 12.7 | 16.03 | 7.51 | 12.5 | 12.5 | 12.5 | 12.5 | 12.5 |
EBITDA | 207.6 | 215.3 | 215.4 | 256.5 | 208.2 | 312.1 | 351.1 | 395.0 | 444.4 | 499.9 |
EBITDA, % | 19.34 | 17.63 | 15.65 | 16.07 | 12.13 | 16.16 | 16.16 | 16.16 | 16.16 | 16.16 |
Depreciation | 87.1 | 89.6 | 101.8 | 98.8 | .0 | 112.2 | 126.2 | 142.0 | 159.7 | 179.7 |
Depreciation, % | 8.12 | 7.34 | 7.4 | 6.19 | 0 | 5.81 | 5.81 | 5.81 | 5.81 | 5.81 |
EBIT | 120.4 | 125.7 | 113.6 | 157.7 | 208.2 | 199.9 | 224.9 | 253.0 | 284.7 | 320.2 |
EBIT, % | 11.22 | 10.29 | 8.25 | 9.87 | 12.13 | 10.35 | 10.35 | 10.35 | 10.35 | 10.35 |
Total Cash | 49.2 | 17.9 | 24.3 | 23.7 | 46.5 | 46.4 | 52.2 | 58.7 | 66.0 | 74.3 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 198.5 | 251.8 | 298.3 | 326.1 | 349.0 | 392.2 | 441.2 | 496.4 | 558.4 | 628.2 |
Account Receivables, % | 18.49 | 20.62 | 21.67 | 20.43 | 20.33 | 20.31 | 20.31 | 20.31 | 20.31 | 20.31 |
Inventories | 149.3 | 155.7 | 208.8 | 239.7 | 247.1 | 275.2 | 309.5 | 348.2 | 391.7 | 440.7 |
Inventories, % | 13.91 | 12.75 | 15.17 | 15.01 | 14.4 | 14.25 | 14.25 | 14.25 | 14.25 | 14.25 |
Accounts Payable | 51.6 | 76.9 | 110.8 | 120.3 | 101.5 | 125.9 | 141.6 | 159.3 | 179.2 | 201.6 |
Accounts Payable, % | 4.8 | 6.29 | 8.05 | 7.53 | 5.91 | 6.52 | 6.52 | 6.52 | 6.52 | 6.52 |
Capital Expenditure | -51.4 | -53.5 | -74.7 | -119.9 | -105.6 | -109.2 | -122.8 | -138.2 | -155.4 | -174.8 |
Capital Expenditure, % | -4.79 | -4.38 | -5.43 | -7.51 | -6.15 | -5.65 | -5.65 | -5.65 | -5.65 | -5.65 |
Tax Rate, % | 18.75 | 18.75 | 18.75 | 18.75 | 18.75 | 18.75 | 18.75 | 18.75 | 18.75 | 18.75 |
EBITAT | 107.9 | 120.4 | 99.2 | 133.2 | 169.2 | 175.4 | 197.3 | 221.9 | 249.7 | 280.9 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -152.6 | 122.1 | 60.7 | 62.8 | 14.5 | 131.6 | 133.0 | 149.6 | 168.3 | 189.4 |
WACC, % | 8.4 | 8.47 | 8.38 | 8.35 | 8.32 | 8.38 | 8.38 | 8.38 | 8.38 | 8.38 |
PV UFCF | ||||||||||
SUM PV UFCF | 600.8 | |||||||||
Long Term Growth Rate, % | 3.00 | |||||||||
Free cash flow (T + 1) | 195 | |||||||||
Terminal Value | 3,624 | |||||||||
Present Terminal Value | 2,423 | |||||||||
Enterprise Value | 3,024 | |||||||||
Net Debt | 1,052 | |||||||||
Equity Value | 1,971 | |||||||||
Diluted Shares Outstanding, MM | 36 | |||||||||
Equity Value Per Share | 55.30 |
What You Will Get
- Real ITGR Financials: Access to historical and projected data for precise valuation.
- Adjustable Inputs: Customize WACC, tax rates, revenue growth, and capital expenditures.
- Automatic Calculations: Intrinsic value and NPV are computed in real-time.
- Scenario Analysis: Evaluate various scenarios to assess Integer Holdings Corporation’s future performance.
- Clear and Intuitive Design: Designed for professionals while remaining user-friendly for newcomers.
Key Features
- Accurate Integer Financials: Gain access to reliable pre-loaded historical data and future forecasts.
- Adjustable Forecast Parameters: Modify yellow-highlighted fields such as WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic adjustments to DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly charts and summaries to present your valuation findings clearly.
- Designed for All Skill Levels: A straightforward, intuitive layout tailored for investors, CFOs, and consultants.
How It Works
- Download the Template: Gain immediate access to the Excel-based ITGR DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and additional parameters.
- Instant Calculations: The model automatically recalculates Integer Holdings Corporation’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Utilize the outcomes to inform your investment or financial analysis.
Why Choose This Calculator for Integer Holdings Corporation (ITGR)?
- Accuracy: Utilizes real Integer Holdings financial data for precise calculations.
- Flexibility: Allows users to easily test and adjust inputs as needed.
- Time-Saving: Eliminate the need to create a DCF model from the ground up.
- Professional-Grade: Crafted with the precision and usability expected by CFOs.
- User-Friendly: Intuitive interface suitable for users without extensive financial modeling skills.
Who Should Use This Product?
- Investors: Evaluate Integer Holdings Corporation’s (ITGR) valuation before making investment decisions.
- CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts.
- Startup Founders: Understand the valuation processes of established companies like Integer Holdings Corporation.
- Consultants: Provide clients with detailed and professional valuation analyses.
- Students and Educators: Utilize current data to learn and teach valuation strategies effectively.
What the Template Contains
- Comprehensive DCF Model: Editable template featuring thorough valuation calculations.
- Real-World Data: Integer Holdings Corporation’s (ITGR) historical and projected financials preloaded for analysis.
- Customizable Parameters: Modify WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights.
- Key Ratios: Integrated analysis for assessing profitability, efficiency, and leverage.
- Dashboard with Visual Outputs: Charts and tables for clear, actionable results.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.